Google+ Followers

Friday, February 24, 2017

Check Out Our New Look

Here is our February Issue of CCFA'S Newsletter Check out our New Look. Letter from our President & CEO For the past 50 years, the Foundation has worked to improve the lives of patients living with Crohn's and colitis, and to find cures for these debilitating digestive diseases. I am pleased to share with you the exciting news that today the Foundation unveiled its new brand, which includes a new logo with a unifying symbol. This is reflective of our commitment and determination to uniting members of the IBD community to care and cure, and to guide the Foundation into the future. That's not the only difference—we are simplifying our name to the Crohn's & Colitis Foundation to place greater emphasis on the diseases we are working to cure. We are excited to share our new brand, and can't wait to work with each and every one of you to continue the pursuit of our mission. Best, Michael Osso President & CEO Thank You to Our Team Challenge Family! The overwhelming feeling of love and hope at the Inspirational Pasta Party among the Mardi Gras floats…The sense of family and community gained from meeting new friends from across the country…The rush of accomplishment, gratitude, strength, and resolve as you cross the finish line hand-in-hand with your coach. These are just a few of the moments that make Team Challenge event weekend truly life changing. This month, 288 teammates from across the country came together to run and walk the Rock 'n' Roll New Orleans 10K, Half Marathon, and Marathon. They raised more than $1.35 million to help us fight Crohn's & colitis—which is incredible! Thank you for your hard work, dedication, and heart. Get a taste of what it's like to be a part of our #TCfamily. Click HERE to see video & photo highlights from our event in New Orleans earlier this month. Join us this year at a 5k, 10k, Half Marathon, Marathon, Triathlon, IRONMAN®, cycle event, or turn anything else into a fundraiser when you Race in Orange. JOIN US ► Colorectal Cancer & IBD Twitter Chat March is Colorectal Cancer (CRC) Awareness Month. After eight years of symptoms, patients with ulcerative colitis or Crohn's disease involving the colon are at an increased risk for developing colorectal cancer; however, it's important to know that CRC is highly treatable when detected early. Join the Crohn's & Colitis Foundation, Dr. Karlee Ausk of the Swedish Inflammatory Bowel Disease Center, and ulcerative colitis patient Will Lanier on March 22 from 8-9 p.m. EST for a Twitter chat about colorectal cancer, IBD, and how you can minimize your risk of developing CRC. Follow along or participate in the chat using the hashtag #IBDchat. #IBDCHAT ► Donate to the Foundation Support the organization that has been dedicated to finding IBD treatments and cures for 50 years. IBD & Dating For some people with IBD, the thought of dating or being intimate may be daunting. To provide some guidance in this area, we have several resources available that may help, including our "Being Intimate with IBD" video. Please reach out to our IBD Help Center for additional information at info@ccfa.org. Walk With Us This Spring! We will Take Steps in 68 communities this spring to raise funds and awareness for the 1.6 million people living with IBD. Connect with other patients, families, healthcare professionals, and caregivers. Bigger than one day, we're a family! Register your team today. REGISTER ► Camp Oasis—Summer Is Right Around The Corner! Camp Oasis is a fun environment where kids learn, play, and meet others with IBD. If you know a child who might be interested, visit our website for more information and to apply! We’re also looking for dedicated, compassionate people to serve as camp counselors and members of our Medical Team. Learn more here. LEARN MORE ► Crohn's & Colitis Foundation provides a comprehensive database of studies, clinical trials, and other research opportunities on Crohn's disease and ulcerative colitis. Here is one of the recently added studies: An Open-Label, 2-Part, Multicenter, Post-marketing Study to Evaluate the Effect of Moderately or Severely Active Ulcerative Colitis or Crohn’s Disease on Cytochrome P-450 Enzyme Substrates Compared to Healthy Subjects and the Effect of Vedolizumab Treatment on Cytochrome P-450 Enzyme Substrates in Subjects With Ulcerative Colitis or Crohn’s Disease. Deciding whether to participate in a clinical trial is an important personal decision, best made with a full understanding of the drug development process and a participant's role.
7​33 Th​ird Av​en​ue, Sui​te 51​0, Ne​w Y​ork,​ N​Y 10​01​7 www.crohnscolitisfoundation.org | 8​00-​93​2-​2​423 Talk with an I​BD Info​rmation Specialist at 88​8.M​y.Gu​t.P​ain | 8​88-​69​4-8​87​2

No comments:

Post a Comment